In this issue:
Targeting thalamic circuits rescues motor and mood deficits in PD mice
Safety, tolerability and pharmacokinetics of oligomer modulator, anle138b
Distressing dreams increase PD risk
CSF neurofilament heavy protein and clinical progression in PD
Polygenic resilience modulates penetrance of PD genetic risk factors
Motor progression and nigrostriatal neurodegeneration in PD
First-in-human study of UB-312, an α-synuclein peptide vaccine
Automated MRPI 2.0 for distinguishing PSP-parkinsonism from PD
Updated recommendations on invasive therapies for PD
Establishing gene regulatory networks from PD risk loci
Please login below to download this issue (PDF)